The Proteome of Extracellular Vesicles Released from Pulmonary Microvascular Endothelium Reveals Impact of Oxygen Conditions on Biotrauma

Author:

Schaubmayr Wolfgang1ORCID,Hochreiter Beatrix1,Hunyadi-Gulyas Eva2ORCID,Riegler Louise3,Schmidt Katy4,Tiboldi Akos1ORCID,Moser Bernhard5ORCID,Klein Klaus U.1,Krenn Katharina1ORCID,Scharbert Gisela1,Mohr Thomas6ORCID,Schmid Johannes A.7ORCID,Spittler Andreas8ORCID,Tretter Verena1ORCID

Affiliation:

1. Department of Anesthesia, General Intensive Care and Pain Medicine, Medical University of Vienna, 1090 Vienna, Austria

2. Laboratory of Proteomics Research, HUN-REN Biological Research Centre, 6726 Szeged, Hungary

3. Department of Orthopedics and Trauma Surgery, Medical University of Vienna, 1090 Vienna, Austria

4. Core Facility of Cell Imaging and Ultrastructure Research, University of Vienna, 1090 Vienna, Austria

5. Department of Thoracic Surgery, Medical University of Vienna, 1090 Vienna, Austria

6. Institute of Cancer Research, Department of Medicine I, Comprehensive Cancer Center, Medical University of Vienna, 1090 Vienna, Austria

7. Institute of Vascular Biology and Thrombosis Research, Medical University of Vienna, 1090 Vienna, Austria

8. Department of Surgery and Core Facility Flow Cytometry, Medical University of Vienna, 1090 Vienna, Austria

Abstract

The lung can experience different oxygen concentrations, low as in hypoxia, high as under supplemental oxygen therapy, or oscillating during intermittent hypoxia as in obstructive sleep apnea or intermittent hypoxia/hyperoxia due to cyclic atelectasis in the ventilated patient. This study aimed to characterize the oxygen-condition-specific protein composition of extracellular vesicles (EVs) released from human pulmonary microvascular endothelial cells in vitro to decipher their potential role in biotrauma using quantitative proteomics with bioinformatic evaluation, transmission electron microscopy, flow cytometry, and non-activated thromboelastometry (NATEM). The release of vesicles enriched in markers CD9/CD63/CD81 was enhanced under intermittent hypoxia, strong hyperoxia and intermittent hypoxia/hyperoxia. Particles with exposed phosphatidylserine were increased under intermittent hypoxia. A small portion of vesicles were tissue factor-positive, which was enhanced under intermittent hypoxia and intermittent hypoxia/hyperoxia. EVs from treatment with intermittent hypoxia induced a significant reduction of Clotting Time in NATEM analysis compared to EVs isolated after normoxic exposure, while after intermittent hypoxia/hyperoxia, tissue factor in EVs seems to be inactive. Gene set enrichment analysis of differentially expressed genes revealed that EVs from individual oxygen conditions potentially induce different biological processes such as an inflammatory response under strong hyperoxia and intermittent hypoxia/hyperoxia and enhancement of tumor invasiveness under intermittent hypoxia.

Funder

Austrian Science Fund

Apeptico Forschung und Entwicklung GmbH

Alterras Therapeutics GmbH

Department of Anesthesia, General Intensive Care and Pain Therapy

EU’s Horizon 2020 research and innovation program

Publisher

MDPI AG

Cited by 1 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3